NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S: Financial statements 2015
CVR: 33249098
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S (CVR 33249098) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 60,441,747 and a net result of DKK 45,386,395 compared with DKK 32,351,010 the year before. That is an increase of 44% compared with the year before. Equity in the 2015 report amounted to DKK 45,981,777. The solvency ratio was 92.3%.
- Gross Profit
- DKK 60,441,747
- Profit/Loss
- DKK 45,386,395
- Equity
- DKK 45,981,777
- Total Assets
- DKK 49,834,240
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 60.4 mio. | 45.4 mio. | 46 mio. | - |
| 2014 | - | 42 mio. | 32.4 mio. | 38.6 mio. | - |
| 2013 | - | 4.2 mio. | 3.2 mio. | 6.2 mio. | - |
| 2012 | - | - | - | 500 t. | - |
Official annual report
How creditworthy is NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S has published its annual report for 2014. Gross profit came to DKK 41,981,534, and the net result was DKK 32,351,010.
About NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S was a Danish company of the type Aktieselskab based in Herlev, founded in 2010. The company has been dissolved on 25 May 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. According to the 2019 annual report, the company had an average of 0 employees. In 2019, the company reported a gross profit of DKK 248,136 and a net result of DKK 164,772 compared with DKK 954,488 the year before. Equity in the 2019 report amounted to DKK 725,098.